This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Baxter Healthcare Sa, Baxter International Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2023
Title: Adam Christopher Mercer: Innovator in Medical Technology
Introduction
Adam Christopher Mercer is a notable inventor based in Chicago, IL. He has made significant contributions to the field of medical technology, particularly in the development of thrombin materials for treating bleeding wounds. His innovative approach has the potential to enhance patient care and improve outcomes in emergency situations.
Latest Patents
Mercer's most recent patent is titled "Spray-dried thrombin and methods of using and making spray-dried thrombin." This patent describes spray-dried thrombin materials obtained from feedstock solutions comprising less than 5% by weight albumin and excluding trehalose or other excipients. The patent also outlines methods for manufacturing these thrombin materials and their application in treating bleeding wounds. The methods of use include applying reconstituted spray-dried thrombin topically to a bleeding site, optionally in conjunction with gelatin.
Career Highlights
Throughout his career, Adam Mercer has worked with prominent companies in the healthcare sector, including Baxter Healthcare and Baxter International Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.
Collaborations
Mercer has collaborated with talented individuals such as Alyssa Sanders and Alexander Wesley Scott. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the medical field.
Conclusion
Adam Christopher Mercer is a distinguished inventor whose work in medical technology has the potential to revolutionize the treatment of bleeding wounds. His innovative patent and collaborations with industry professionals highlight his commitment to improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile